|
Post by JHam on Nov 17, 2020 13:46:27 GMT
|
|
|
Post by lcd on Nov 17, 2020 14:05:24 GMT
That sucks for the ALS community. It looks like they did get some clinically meaningful responses for early stage patients so there is still some hope, but as an investor I cut losses on my few remaining shares pre-market.
|
|